Kelly A Romano - Director, Athira Pharma, Inc

As of May 27, 2022


What is Kelly A Romano's Net Worth?

The current estimated net worth of Athira Pharma, Inc's Director, Kelly A Romano, is estimated to be about $758.09K . Kelly A Romano owns about 8,315 units of Athira Pharma, Inc common stock. In the last 2 years at Athira Pharma, Inc, Kelly A Romano has sold an estimated value of $0 worth.

What is Kelly A Romano's Past Insider Trading?

Kelly A Romano's largest purchase order was 8,000 units , worth over $104.88K on April 1, 2022. In total, Kelly A Romano has made about 3 transactions over 2 years of their time at Athira Pharma, Inc. Kelly A Romano usually trades in December, May and April, with the busiest year in 2022.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Kelly A Romano's' Mailing Address?

  • Mailing address is C/o Dorman Products, Inc. 3400 East Walnut Street Colmar PA 18915 PA

What are Athira Pharma, Inc's Past Insider Trades?

Athira Pharma, Inc's most recent insider trade came on June 24, 2022 by Mark Worthington who sold 2,614 units worth $7.03K . In the last 2 years, insiders at Athira Pharma, Inc have sold an estimated value of $53.79K and bought an estimated value of $56.21M worth of shares. Insider trading is most common in June, with the busiest year in 2022. The most active traders at the company are Glenna Mileson, Chief Financial Officer,  Kevin Church, Executive VP,  and John M. Fluke, Director .

Athira Pharma, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1